Skip to main content

This job has expired

Professor of Cancer Studies & Joint Head of School of Cancer & Pharmaceutical Sciences

London (Greater) (GB)
Closing date
17 Jun 2024

Job Details

Professor of Cancer Studies & Joint Head of School of Cancer & Pharmaceutical Sciences (Head of Comprehensive Cancer Centre)

King’s College London is an internationally renowned university delivering exceptional education and world-leading research. We are dedicated to driving positive and sustainable change in society and realising our vision of making the world a better place.

The Faculty of Life Sciences and Medicine is one of the largest and most successful centres for research and education in the UK, with extensive global partnerships. With world-renowned researchers and a passionate student body, it is committed to encouraging innovative and progressive collaboration, as well as new ways to work and learn.

The Faculty has a student community which consists of more than 5,000 students who are supported by over 500 leading scientists and educators. It delivers a wide range of courses for talented aspiring clinicians and health professionals in partnership with KCL’s NHS partners, including Guy’s, King’s College and St Thomas’ Hospitals.

The Faculty of Life Science and Medicine seeks to appoint a Joint Head of the School of Cancer & Pharmaceutical Sciences (Head of Comprehensive Cancer Centre). The School of Cancer & Pharmaceutical Sciences comprises the Comprehensive Cancer Centre (CCC) and the Institute of Pharmaceutical Sciences. King’s CCC is the academic arm of one of the leading cancer centres in Europe, with outstanding basic through to clinical research being conducted across a broad range of areas.

In addition to the Head of School position, the role holder will be appointed to a permanent Professorial position in the area of Oncology in the School of Cancer and Pharmaceutical Sciences. The post is open to either clinical or non-clinical academics with it being essential for the role holder to have an excellent grasp of the full range of academic activities from basic science through to clinical translation.

The successful candidate will be an outstanding academic of international reputation in oncology who is an experienced strategic leader with an understanding and appreciation of the breadth of research conducted within the CCC.

Applicants should submit a full curriculum vitae, including comprehensive details of key achievements and responsibilities, along with a covering letter addressed to The Selection Committee, which fully addresses the competencies summarised in the role description and outlines their interest in the role.

Completed applications should be uploaded at quoting reference number 7323.

The closing date for applications is 9:00am (BST) on Monday 17th June 2024.

For a conversation in confidence, or if you require documentation in an alternative format, please contact Dr Urvashi Ramphul at and +44 (0) 20 7340 6280.

If any reasonable adjustments are required for assistance in the selection process, please advise us of these so that we can make appropriate arrangements.

Should you require access to these documents in alternative formats, please contact Sarah Snelling on

If you have comments that would support us to improve access to documentation, or our application processes more generally, please do not hesitate to contact us via

Privacy Policy

Protecting your personal data is of the utmost importance to Perrett Laver and we take this responsibility very seriously. Any information obtained by our trading divisions is held and processed in accordance with the relevant data protection legislation. The data you provide us with is securely stored on our computerised database and transferred to our clients for the purposes of presenting you as a candidate and/or considering your suitability for a role you have registered interest in.

Perrett Laver is a Data Controller and a Data Processor, and our legal basis for processing your personal data is ‘Legitimate Interests’. You have the right to object to us processing your data in this way. For more information about this, your rights, and our approach to Data Protection and Privacy, please visit our website


King's College London is one of the top 20 universities in the world and among the oldest in England. King's has more than 27,600 students (of whom nearly 10,500 are graduate students) from some 150 countries worldwide, and some 6,800 staff.

King's has an outstanding reputation for world-class teaching and cutting-edge research. In the 2014 Research Excellence Framework (REF) King’s was ranked 6th nationally in the ‘power’ ranking, which takes into account both the quality and quantity of research activity, and 7th for quality according to Times Higher Education rankings. Eighty-four per cent of research at King’s was deemed ‘world-leading’ or ‘internationally excellent’ (3* and 4*). The university is in the top seven UK universities for research earnings and has an overall annual income of more than £684 million.

King's has a particularly distinguished reputation in the humanities, law, the sciences (including a wide range of health areas such as psychiatry, medicine, nursing and dentistry) and social sciences including international affairs. It has played a major role in many of the advances that have shaped modern life, such as the discovery of the structure of DNA and research that led to the development of radio, television, mobile phones and radar.

King's College London and Guy's and St Thomas', King's College Hospital and South London and Maudsley NHS Foundation Trusts are part of King's Health Partners. King's Health Partners Academic Health Sciences Centre (AHSC) is a pioneering global collaboration between one of the world's leading research-led universities and three of London's most successful NHS Foundation Trusts, including leading teaching hospitals and comprehensive mental health services. For more information, visit:

King’s £600 million campaign, World questions|KING’s answers, has delivered huge global impact in areas where King’s has particular expertise. Philanthropic support has funded new research to save young lives at Evelina London Children’s Hospital; established the King’s Dickson Poon School of Law as a worldwide leader in transnational law; built a new Cancer Centre at Guy’s Hospital; allowed unique collaboration between leading neuroscientists to fast-track new treatments for Alzheimer’s, Parkinson’s, motor neurone disease, depression and schizophrenia at the new Maurice Wohl Clinical Neuroscience Institute; created the Cicely Saunders Institute: the first academic institution in the world dedicated to palliative care, and supported the King’s Sierra Leone Partnership in the Ebola crisis. Donations provide over 300 of the most promising students with scholarships and bursaries each year. More information about the campaign is available at

Company info

Get job alerts

Create a job alert and receive personalised job recommendations straight to your inbox.

Create alert